FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890178834> ?p ?o ?g. }

• W2890178834 endingPage "e0006870" @default.
• W2890178834 startingPage "e0006870" @default.
• W2890178834 abstract "Background Estimates of current global rabies mortality range from 26,000 to 59,000 deaths per annum. Although pre-exposure prophylaxis using inactivated rabies virus vaccines (IRVs) is effective, it requires two to three doses and is regarded as being too expensive and impractical for inclusion in routine childhood immunization programmes. Methodology/ Principal findings Here we report the development of a simian-adenovirus-vectored rabies vaccine intended to enable cost-effective population-wide pre-exposure prophylaxis against rabies. ChAdOx2 RabG uses the chimpanzee adenovirus serotype 68 (AdC68) backbone previously shown to achieve pre-exposure protection against rabies in non-human primates. ChAdOx2 differs from AdC68 in that it contains the human adenovirus serotype 5 (AdHu5) E4 orf6/7 region in place of the AdC68 equivalents, enhancing ease of manufacturing in cell lines which provide AdHu5 E1 proteins in trans. We show that immunogenicity of ChAdOx2 RabG in mice is comparable to that of AdC68 RabG and other adenovirus serotypes expressing rabies virus glycoprotein. High titers of rabies virus neutralizing antibody (VNA) are elicited after a single dose. The relationship between levels of VNA activity and rabies virus glycoprotein monomer-binding antibody differs after immunization with adenovirus-vectored vaccines and IRV vaccines, suggesting routes to further enhancement of the efficacy of the adenovirus-vectored candidates. We also demonstrate that ChAdOx2 RabG can be thermostabilised using a low-cost method suitable for clinical bio-manufacture and ambient-temperature distribution in tropical climates. Finally, we show that a dose-sparing effect can be achieved by formulating ChAdOx2 RabG with a simple chemical adjuvant. This approach could lower the cost of ChAdOx2 RabG and other adenovirus-vectored vaccines. Conclusions/ Significance ChAdOx2 RabG may prove to be a useful tool to reduce the human rabies death toll. We have secured funding for Good Manufacturing Practice- compliant bio-manufacture and Phase I clinical trial of this candidate." @default.
• W2890178834 created "2018-09-27" @default.
• W2890178834 creator A5005393076 @default.
• W2890178834 creator A5009271765 @default.
• W2890178834 creator A5020456334 @default.
• W2890178834 creator A5023709369 @default.
• W2890178834 creator A5026176925 @default.
• W2890178834 creator A5027463016 @default.
• W2890178834 creator A5033662388 @default.
• W2890178834 creator A5033873978 @default.
• W2890178834 creator A5046793340 @default.
• W2890178834 creator A5049604548 @default.
• W2890178834 creator A5056099235 @default.
• W2890178834 creator A5064651300 @default.
• W2890178834 creator A5070461413 @default.
• W2890178834 creator A5071986741 @default.
• W2890178834 creator A5089240757 @default.
• W2890178834 creator A5089998149 @default.
• W2890178834 date "2018-10-29" @default.
• W2890178834 modified "2023-10-14" @default.
• W2890178834 title "A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis" @default.
• W2890178834 cites W1506151812 @default.
• W2890178834 cites W1968653962 @default.
• W2890178834 cites W1970191976 @default.
• W2890178834 cites W1972258033 @default.
• W2890178834 cites W1982906382 @default.
• W2890178834 cites W1989888538 @default.
• W2890178834 cites W1997549588 @default.
• W2890178834 cites W2004497415 @default.
• W2890178834 cites W2013245408 @default.
• W2890178834 cites W2020405271 @default.
• W2890178834 cites W2030446202 @default.
• W2890178834 cites W2032264322 @default.
• W2890178834 cites W2032755224 @default.
• W2890178834 cites W2033293873 @default.
• W2890178834 cites W2035738127 @default.
• W2890178834 cites W2038220108 @default.
• W2890178834 cites W2047324082 @default.
• W2890178834 cites W2055320689 @default.
• W2890178834 cites W2055623470 @default.
• W2890178834 cites W2057842024 @default.
• W2890178834 cites W2063629987 @default.
• W2890178834 cites W2065928396 @default.
• W2890178834 cites W2067087090 @default.
• W2890178834 cites W2073034493 @default.
• W2890178834 cites W2076119221 @default.
• W2890178834 cites W2077271883 @default.
• W2890178834 cites W2090211342 @default.
• W2890178834 cites W2097486682 @default.
• W2890178834 cites W2104823480 @default.
• W2890178834 cites W2108537199 @default.
• W2890178834 cites W2122843610 @default.
• W2890178834 cites W2128297456 @default.
• W2890178834 cites W2130314959 @default.
• W2890178834 cites W2131315410 @default.
• W2890178834 cites W2133018020 @default.
• W2890178834 cites W2136546144 @default.
• W2890178834 cites W2137181878 @default.
• W2890178834 cites W2140284275 @default.
• W2890178834 cites W2140446852 @default.
• W2890178834 cites W2147803077 @default.
• W2890178834 cites W2164740904 @default.
• W2890178834 cites W2168630917 @default.
• W2890178834 cites W2186661429 @default.
• W2890178834 cites W2308039846 @default.
• W2890178834 cites W2342710380 @default.
• W2890178834 cites W2343314930 @default.
• W2890178834 cites W2492777583 @default.
• W2890178834 cites W2519763881 @default.
• W2890178834 cites W2531412104 @default.
• W2890178834 cites W2543965487 @default.
• W2890178834 cites W2765332961 @default.
• W2890178834 cites W4210779118 @default.
• W2890178834 cites W4211133799 @default.
• W2890178834 doi "https://doi.org/10.1371/journal.pntd.0006870" @default.
• W2890178834 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6224154" @default.
• W2890178834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30372438" @default.
• W2890178834 hasPublicationYear "2018" @default.
• W2890178834 type Work @default.
• W2890178834 sameAs 2890178834 @default.
• W2890178834 citedByCount "34" @default.
• W2890178834 countsByYear W28901788342019 @default.
• W2890178834 countsByYear W28901788342020 @default.
• W2890178834 countsByYear W28901788342021 @default.
• W2890178834 countsByYear W28901788342022 @default.
• W2890178834 countsByYear W28901788342023 @default.
• W2890178834 crossrefType "journal-article" @default.
• W2890178834 hasAuthorship W2890178834A5005393076 @default.
• W2890178834 hasAuthorship W2890178834A5009271765 @default.
• W2890178834 hasAuthorship W2890178834A5020456334 @default.
• W2890178834 hasAuthorship W2890178834A5023709369 @default.
• W2890178834 hasAuthorship W2890178834A5026176925 @default.
• W2890178834 hasAuthorship W2890178834A5027463016 @default.
• W2890178834 hasAuthorship W2890178834A5033662388 @default.
• W2890178834 hasAuthorship W2890178834A5033873978 @default.
• W2890178834 hasAuthorship W2890178834A5046793340 @default.
• W2890178834 hasAuthorship W2890178834A5049604548 @default.
• W2890178834 hasAuthorship W2890178834A5056099235 @default.

• next